Healthy Returns: AbbVie is the newest potential weight loss drug market player – CNBC

Healthy Returns: AbbVie is the newest potential weight loss drug market player  CNBC

Commercial insurance coverage for GLP-1s still limited – TechTarget

Commercial insurance coverage for GLP-1s still limited  TechTarget

Boots sold weight-loss jabs to underage girl ‘without checks’ – The Times

Boots sold weight-loss jabs to underage girl ‘without checks’  The Times

Faced with exploding costs, Pa. seeks clampdown on Medicaid-funded use of Ozempic and other weight-loss drugs – Pittsburgh Post-Gazette

Faced with exploding costs, Pa. seeks clampdown on Medicaid-funded use of Ozempic and other weight-loss drugs  Pittsburgh…

Antibody drug conjugates: Tackling the unsolved challenges with novel technologies

ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for…

Antibody drug conjugates: Tackling the unsolved challenges with novel technologies

ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for…

The science behind over-hyped weight loss supplements doesn’t stack up – The Telegraph

The science behind over-hyped weight loss supplements doesn’t stack up  The Telegraph

Over half of adults are predicted to be overweight by 2050. Here’s why weight-loss drugs aren’t a cure – Quartz

Over half of adults are predicted to be overweight by 2050. Here’s why weight-loss drugs aren’t…

How weight loss drugs, surgery and awareness contribute to dip in obesity – WESH 2 Orlando

How weight loss drugs, surgery and awareness contribute to dip in obesity  WESH 2 Orlando

Weight loss jab use rising among people with eating disorders, experts warn as NHS chief calls for crackdown – NewsBreak

Weight loss jab use rising among people with eating disorders, experts warn as NHS chief calls…